{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T19:54:29Z","timestamp":1648929269611},"reference-count":52,"publisher":"Royal College of Psychiatrists","issue":"3","license":[{"start":{"date-parts":[[2018,4,26]],"date-time":"2018-04-26T00:00:00Z","timestamp":1524700800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BJPsych open"],"published-print":{"date-parts":[[2018,5]]},"abstract":"<jats:p>Bipolar disorder with comorbid anxiety disorders frequently requires rational polypharmacy, including use of serotonergic psychotropics. These may result in adverse effects, influencing adherence, complicating treatment and confounding diagnoses. Serotonergic non-adherence is associated with discontinuation syndromes. In this complex case with an on\/off\/on\/off design, both dose-dependent buspirone-induced gynecomastia and buspirone discontinuation syndrome with dental pain are reported. Clinicians and patients should consider these findings to maximise treatment adherence, minimise any unnecessary interventions and address unusual adverse effects. Since patients may not voluntarily disclose specific adverse effects and often do not acknowledge non-adherence, clinician-directed questions are required. This case further emphasises the importance of medication and symptom timelines to guide determination of causation for adverse effects. Although findings from this case cannot be generalised, they suggest the need for continued clinician and patient education, as well as the benefit from detailed case reports.<\/jats:p><jats:sec id=\"S2056472418000017_sec_a1\"><jats:title>Declaration of interest<\/jats:title><jats:p>None.<\/jats:p><\/jats:sec>","DOI":"10.1192\/bjo.2018.1","type":"journal-article","created":{"date-parts":[[2018,4,30]],"date-time":"2018-04-30T02:41:22Z","timestamp":1525056082000},"page":"137-141","source":"Crossref","is-referenced-by-count":1,"title":["Bipolar disorder, comorbid anxiety disorders, gynecomastia and dental pain: case analysis with literature review"],"prefix":"10.1192","volume":"4","author":[{"given":"Kenneth R.","family":"Kaufman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronke","family":"Babalola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam","family":"Campeas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa","family":"Coluccio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"170","published-online":{"date-parts":[[2018,4,26]]},"reference":[{"key":"S2056472418000017_ref25","doi-asserted-by":"publisher","DOI":"10.1177\/0269881109359094"},{"key":"S2056472418000017_ref31","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/acps.12514","article-title":"The influence of comorbid disorders on the episodicity of bipolar disorder in youth","volume":"133","author":"Yen","year":"2016","journal-title":"Acta Psychiatr Scand"},{"key":"S2056472418000017_ref51","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1990.tb16909.x"},{"key":"S2056472418000017_ref27","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.2012.01917.x"},{"key":"S2056472418000017_ref4","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/bdi.12419","article-title":"Is age of onset associated with severity, prognosis, and clinical features in bipolar disorder? A meta-analytic review","volume":"18","author":"Joslyn","year":"2016","journal-title":"Bipolar Disord"},{"key":"S2056472418000017_ref34","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-012-0323-6"},{"key":"S2056472418000017_ref32","doi-asserted-by":"publisher","DOI":"10.1002\/hup.612"},{"key":"S2056472418000017_ref30","doi-asserted-by":"publisher","DOI":"10.1001\/archgenpsychiatry.2011.12"},{"key":"S2056472418000017_ref52","first-page":"9","article-title":"Potential adverse effects of discontinuing psychotropic drugs: part 2: antidepressant drugs","volume":"48","author":"Howland","year":"2010","journal-title":"J Psychosoc Nurs Ment Health Serv"},{"key":"S2056472418000017_ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2014.05.017"},{"key":"S2056472418000017_ref50","doi-asserted-by":"publisher","DOI":"10.1159\/000284623"},{"key":"S2056472418000017_ref8","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jad.2016.07.011","article-title":"Prevalence of comorbid bipolar and substance use disorders in clinical settings, 1990\u20132015: systematic review and meta-analysis","volume":"206","author":"Hunt","year":"2016","journal-title":"J Affect Disord"},{"key":"S2056472418000017_ref48","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154"},{"key":"S2056472418000017_ref21","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0327(97)00086-4"},{"key":"S2056472418000017_ref18","first-page":"196","article-title":"The International College of Neuropsychopharmacology (CINP) treatment guidelines for bipolar disorder in adults (CINP-BD-2017), part 4: unmet needs in the treatment of bipolar disorder and recommendations for future research","volume":"20","author":"Fountoulakis","year":"2017","journal-title":"Int J Neuropsychopharmacol"},{"key":"S2056472418000017_ref17","first-page":"87","article-title":"Compliance with maintenance treatment in bipolar disorder","volume":"33","author":"Keck","year":"1997","journal-title":"Psychopharmacol Bull"},{"key":"S2056472418000017_ref35","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0327(00)00299-8"},{"key":"S2056472418000017_ref33","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2012.00989.x"},{"key":"S2056472418000017_ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2015.06.005"},{"key":"S2056472418000017_ref41","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v65n0806"},{"key":"S2056472418000017_ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.janxdis.2008.03.013"},{"key":"S2056472418000017_ref19","doi-asserted-by":"publisher","DOI":"10.1080\/00926230390195524"},{"key":"S2056472418000017_ref15","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-015-2493-8"},{"key":"S2056472418000017_ref7","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jad.2016.06.051","article-title":"Comorbidity of bipolar and substance use disorders in national surveys of general populations, 1990-2015: systematic review and meta-analysis","volume":"206","author":"Hunt","year":"2016","journal-title":"J Affect Disord"},{"key":"S2056472418000017_ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2015.09.015"},{"key":"S2056472418000017_ref45","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-1579"},{"key":"S2056472418000017_ref22","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1R491"},{"key":"S2056472418000017_ref12","first-page":"6","article-title":"The CANMAT task force recommendations for the management of patients with mood disorders and comorbid anxiety disorders","volume":"24","author":"Schaffer","year":"2012","journal-title":"Ann Clin Psychiatry"},{"key":"S2056472418000017_ref43","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1E294"},{"key":"S2056472418000017_ref23","doi-asserted-by":"publisher","DOI":"10.1002\/hup.2429"},{"key":"S2056472418000017_ref16","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)68902-2"},{"key":"S2056472418000017_ref11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2006.00371.x"},{"key":"S2056472418000017_ref2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1136\/eb-2016-102412","article-title":"Prevalence, impact and treatment of generalised anxiety disorder in bipolar disorder: a systematic review and meta-analysis","volume":"19","author":"Preti","year":"2016","journal-title":"Evid Based Ment Health"},{"key":"S2056472418000017_ref13","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0327(14)70006-0"},{"key":"S2056472418000017_ref26","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.08m04994yel"},{"key":"S2056472418000017_ref28","doi-asserted-by":"publisher","DOI":"10.1007\/s00406-009-0085-2"},{"key":"S2056472418000017_ref39","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4741.2011.01080.x"},{"key":"S2056472418000017_ref36","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2012.00993.x"},{"key":"S2056472418000017_ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2011.03.011"},{"key":"S2056472418000017_ref40","doi-asserted-by":"publisher","DOI":"10.1002\/phar.1138"},{"key":"S2056472418000017_ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2015.09.006"},{"key":"S2056472418000017_ref42","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(81)91456-2"},{"key":"S2056472418000017_ref44","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2006.02.003"},{"key":"S2056472418000017_ref24","doi-asserted-by":"publisher","DOI":"10.1159\/000370338"},{"key":"S2056472418000017_ref5","doi-asserted-by":"publisher","DOI":"10.4103\/0253-7176.112202"},{"key":"S2056472418000017_ref46","first-page":"13l01519","article-title":"Treatment of hyperprolactinemia and gynecomastia with adjunctive aripiprazole in 2 men receiving long-acting injectable antipsychotics","volume":"15","author":"Boggs","year":"2013","journal-title":"Prim Care Companion CNS Disord"},{"key":"S2056472418000017_ref29","doi-asserted-by":"crossref","first-page":"e0126530","DOI":"10.1371\/journal.pone.0126530","article-title":"Delays before diagnosis and initiation of treatment in patients presenting to mental health services with bipolar disorder","volume":"10","author":"Patel","year":"2015","journal-title":"PLoS One"},{"key":"S2056472418000017_ref37","doi-asserted-by":"publisher","DOI":"10.1097\/HRP.0000000000000017"},{"key":"S2056472418000017_ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2014.06.053"},{"key":"S2056472418000017_ref14","doi-asserted-by":"publisher","DOI":"10.1176\/ps.2008.59.10.1175"},{"key":"S2056472418000017_ref47","first-page":"152","article-title":"Gynecomastia induced by treatment with tandospirone, a 5-HT1A agonist","volume":"26","author":"Kaneda","year":"2001","journal-title":"J Psychiatry Neurosci"},{"key":"S2056472418000017_ref49","first-page":"60","article-title":"SSRIs and SNRIs: a review of the discontinuation syndrome in children and adolescents","volume":"20","author":"Hosenbocus","year":"2011","journal-title":"J Can Acad Child Adolesc Psychiatry"}],"container-title":["BJPsych Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S2056472418000017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,14]],"date-time":"2019-04-14T21:03:11Z","timestamp":1555275791000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S2056472418000017\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,26]]},"references-count":52,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,5]]}},"alternative-id":["S2056472418000017"],"URL":"https:\/\/doi.org\/10.1192\/bjo.2018.1","relation":{},"ISSN":["2056-4724"],"issn-type":[{"value":"2056-4724","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,26]]}}}